HUTCHMED (China) (HCM) Operating Income (2015 - 2021)
HUTCHMED (China)'s (HCM) quarterly Operating Income came in at $130.4 million in Q2 2021, down 19.36% year-on-year from $161.7 million in Q2 2020, and down 40.9% on a QoQ basis from $220.6 million in Q1 2021.
HUTCHMED (China) (HCM) Operating Income (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 6 years of Operating Income data on file, last reported at $130.4 million in Q2 2021.
- On a quarterly basis, Operating Income fell 19.36% year-over-year to $130.4 million in Q2 2021; TTM through Jun 2021 was $645.6 million, a 193.04% increase from a year earlier, with the FY2025 full-year figure at -$39.2 million, up 10.4% from the prior year.
- Operating Income for Q2 2021 stood at $130.4 million, down from $220.6 million in the prior quarter.
- Over the last five years, Operating Income for HCM reached as high as $220.6 million in Q1 2021 and fell as low as -$161.1 million in Q4 2018.
- Historically, Operating Income has averaged $33.9 million across 4 years, with a median of $25.4 million in 2018.
- Across the five-year window, Operating Income tumbled 343.04% in 2019 and jumped 269.04% in 2020, its largest moves.
- Year by year, Operating Income stood at -$161.1 million in 2018, then soared by 76.14% to -$38.4 million in 2019, then surged by 520.62% to $161.7 million in 2020, then slipped by 19.36% to $130.4 million in 2021.
- Per Business Quant data, the three most recent Operating Income figures were $130.4 million in Q2 2021, $220.6 million in Q1 2021, and $161.7 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 130.37 Mn |
| Mar 31, 2021 | 220.58 Mn |
| Jun 30, 2020 | 161.66 Mn |
| Mar 31, 2020 | 133.04 Mn |
| Dec 31, 2019 | -38.43 Mn |
| Sep 30, 2019 | -35.94 Mn |
| Jun 30, 2019 | -108.06 Mn |
| Mar 31, 2019 | 36.05 Mn |
| Dec 31, 2018 | -161.11 Mn |
| Sep 30, 2018 | 14.79 Mn |
| Jun 30, 2018 | 78.70 Mn |
| Mar 31, 2018 | -25.02 Mn |
| Jun 30, 2016 | 90.74 Mn |
| Jun 30, 2015 | 74.57 Mn |